Announcement of New Director Larry Steranka

Dear Colleagues,

I am pleased to announce that following a comprehensive search, we have selected Larry Steranka, PhD, as senior director of technology transfer and industry collaboration (TTIC) in the Office of the Vice Provost for Research. He will join us on January 1, 2016.

Dr. Steranka received his BA and PhD from Vanderbilt University and completed his postdoctoral training there in pharmacology.

Larry Steranka was most recently the managing director of Cancer Research Technology Inc. CRT Inc is the US subsidiary of CRT Ltd, the commercialization arm of Cancer Research UK, which is the largest independent funder of cancer research worldwide. Larry assumed that post in 2006 to establish a US-based business development function for the foundation and to negotiate and manage its collaboration agreements with companies engaged in oncology R&D in the US.

Before joining Cancer Research Technology, Larry Steranka was the executive director of the technology licensing office at Brandeis University (from 2004 to 2006), an associate director at the Harvard University office (from 2000 to 2004), and director of the Vanderbilt University office (from 1996 to 2000). Larry was second-in-command at the Harvard office, where he oversaw intellectual property commercialization for Harvard School of Public Health and the life sciences at Harvard College, and at Vanderbilt he established an internal venture fund and dedicated business startup function.

Larry Steranka’s industry experience includes two years at Zeneca Pharmaceutical Group and ten years at Nova Pharmaceutical Corporation, where he directed anti-inflammatory drug programs, managed 100 scientists as vice president of research, and served as general manager of Nova after its acquisition by Scios. As an assistant professor at Indiana University School of Medicine, Larry developed a pharmacology course for second-year medical students and established a research program funded from federal as well as industry sources.

The core mission of Tufts’ recently reorganized TTIC is to identify, evaluate, patent, and commercialize University technologies. Our search committee is confident that Larry Steranka is the right person to spearhead these efforts and drive strategic alliances. Larry has worked as a professor and in industry, and he has held leadership positions in technology transfer at three universities. His vision and ability to implement and organize will build upon TTIC’s achievements and provide an exceptional blend of collaboration, innovation, and entrepreneurial spirit.

I would like to thank the members of the search committee for their partnership in making this appointment an overwhelming success. Please join me in welcoming Larry Steranka to Tufts. He invites you to contact him at starting next week.


Diane L. Souvaine
Vice Provost for Research